Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07478354 · ClinicalTrials.gov registry record

Heart Institute BioRepository (HIBR) for Pediatric Heart Disease

A clinical trial of Cardiovascular Diseases (CVD), sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
5,000
Enrollment target
1
Study location

NCT07478354: Recruiting study of Cardiovascular Diseases (CVD), sponsored by Children's Hospital Medical Center, Cincinnati.

NCT07478354 is a study of Cardiovascular Diseases (CVD) that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 5,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07478354, a study of Cardiovascular Diseases (CVD), is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
5,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this protocol is to redefine the Heart Institute BioRepository (HIBR) to facilitate Investigator-initiated and programmatic basic, translational, clinical and outcomes research. For the purposes of this protocol, "tissue" will refer to any gross specimen obtained from a patient, including but not limited to blood, cardiovascular tissue, urine, saliva, and other tissues and bodily fluids, including explanted non-human prosthetics or grafts. In this context, "tissue" is synonymous with "sample" or "specimen." A "BioRepository" functions to systematically collect, maintain and govern tissue specimens.

Primary Outcome

Blood samples will be collected for preparation of plasma and serum, extraction of DNA and isolation of circulating cells. Future analysis includes genotype-phenotype relationships using blood-tissue pairs.

Study Locations (1)

Ohio

  • Children's Hospital Medical Center, Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2012-01-27
Est. Completion 2050-01-01

What NCT07478354 shows while recruiting

NCT07478354 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Cardiovascular Diseases (CVD) appearing as the primary indexed condition, and to 0 interventions.

NCT07478354 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07478354 about?

NCT07478354 is a clinical study titled "Heart Institute BioRepository (HIBR) for Pediatric Heart Disease". The purpose of this protocol is to redefine the Heart Institute BioRepository (HIBR) to facilitate Investigator-initiated and programmatic basic, translational, clinical and outcomes research. For the purposes of this protocol, "tissue" will refer to any gross specimen obtained from a patient, inclu...

What is the current status of trial NCT07478354?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2012-01-27. Estimated completion is 2050-01-01.

What conditions does trial NCT07478354 study?

This clinical trial studies the following conditions: Cardiovascular Diseases (CVD).

Who is sponsoring clinical trial NCT07478354?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07478354 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases (CVD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07478354, the US trial registry maintained by the National Library of Medicine. NCT07478354 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.